XFRA ISIN CHANGE

Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA3874371147 Granite REIT LP 03.10.2024 CA3874372053 Granite REIT LP 04.10.2024 Tausch 1:1
US86323X1063 Streamline Health Solutions Inc. 03.10.2024 US86323X2053 Streamline Health Solutions Inc. 04.10.2024 Tausch 15:1
US59564R7089 Biodexa Pharmaceuticals PLC 03.10.2024 US59564R8079 Biodexa Pharmaceuticals PLC 04.10.2024 Tausch 25:1
KYG9845F1090 LakeShore Biopharma Co. Ltd. 03.10.2024 KYG9845F2080 LakeShore Biopharma Co. Ltd. 04.10.2024 Tausch 10:1
US82655M1071 Sify Technologies Ltd. 03.10.2024 US82655M2061 Sify Technologies Ltd. 04.10.2024 Tausch 6:1
MHY8564W1030 Teekay Corp. 03.10.2024 BMG8726T1053 Teekay Corp. 04.10.2024 Tausch 1:1

Treibt Nvidias KI-Boom den Uranpreis?

In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.

Hier klicken

Zeit	Aktuelle Nachrichten
04.12.	Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer
22.11.	Biodexa Pharmaceuticals PLC: Result of General Meeting	November 22, 2024 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Result of General Meeting Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ: BDRX), a clinical stage biopharmaceutical... ► Artikel lesen
21.11.	Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic	CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical... ► Artikel lesen
12.11.	Biodexa Pharmaceuticals erfüllt wieder Nasdaq-Anforderungen
12.11.	Biodexa Pharmaceuticals regains Nasdaq compliance

Zeit

Aktuelle Nachrichten

04.12.

Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer

22.11.

Biodexa Pharmaceuticals PLC: Result of General Meeting

November 22, 2024 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Result of General Meeting Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ: BDRX), a clinical stage biopharmaceutical...
► Artikel lesen

21.11.

Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical...
► Artikel lesen

12.11.

Biodexa Pharmaceuticals erfüllt wieder Nasdaq-Anforderungen

12.11.

Biodexa Pharmaceuticals regains Nasdaq compliance

Zeit	Aktuelle Nachrichten
Sa	Granite Real Estate Investment Trust: Granite REIT to release 2024 results Feb. 26
Mi	Granite REIT raises dividend by 3%
Mi	Granite Real Estate Investment Trust: Granite REIT to pay 28.33-cent distribution Jan. 15
Di	GRANITE REAL ESTATE INVESTMENT TRUST - 6-K, Report of foreign issuer
03.12.	Is Granite REIT stock a buy for its 4.3% dividend yield?

Zeit

Aktuelle Nachrichten

Granite Real Estate Investment Trust: Granite REIT to release 2024 results Feb. 26

Granite REIT raises dividend by 3%

Granite Real Estate Investment Trust: Granite REIT to pay 28.33-cent distribution Jan. 15

GRANITE REAL ESTATE INVESTMENT TRUST - 6-K, Report of foreign issuer

03.12.

Is Granite REIT stock a buy for its 4.3% dividend yield?

Zeit	Aktuelle Nachrichten
Do	LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance	Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY Gross margin... ► Artikel lesen
13.12.	LakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China	BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation... ► Artikel lesen
12.12.	LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer
01.11.	LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer
29.10.	LakeShore Biopharma erfüllt wieder Nasdaq-Anforderungen

Zeit

Aktuelle Nachrichten

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY Gross margin...
► Artikel lesen

13.12.

LakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation...
► Artikel lesen

12.12.

LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer

01.11.

LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer

29.10.

LakeShore Biopharma erfüllt wieder Nasdaq-Anforderungen

Zeit	Aktuelle Nachrichten
09.12.	Sify Technologies launches data center for India's Supreme Court
05.12.	Sify Technologies Limited: Sify-built Data Center for the Supreme Court of India goes Live
04.11.	Sify Technologies Limited: Sify Technologies Partners with Cisco ThousandEyes to Help Enterprises Accelerate their Digital Transformation Journey
25.10.	Sify Technologies launches GPU cloud offering
23.10.	Sify Technologies startet GPU-Cloud-Dienst für Unternehmen

Zeit

Aktuelle Nachrichten

09.12.

Sify Technologies launches data center for India's Supreme Court

05.12.

Sify Technologies Limited: Sify-built Data Center for the Supreme Court of India goes Live

04.11.

Sify Technologies Limited: Sify Technologies Partners with Cisco ThousandEyes to Help Enterprises Accelerate their Digital Transformation Journey

25.10.

Sify Technologies launches GPU cloud offering

23.10.

Sify Technologies startet GPU-Cloud-Dienst für Unternehmen

Zeit	Aktuelle Nachrichten
Fr	STREAMLINE HEALTH SOLUTIONS INC. - 10-Q, Quarterly Report
Mi	Streamline Health Solutions, Inc.: Streamline Health Expands Presence In Texas with 400-Bed Health System for RevID
Mo	Streamline Health GAAP EPS of -$0.61 misses by $0.16, revenue of $4.42M misses by $0.89M
Mo	Streamline Health Solutions, Inc.: Streamline Health Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline	Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS... ► Artikel lesen
Mo	STREAMLINE HEALTH SOLUTIONS INC. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

STREAMLINE HEALTH SOLUTIONS INC. - 10-Q, Quarterly Report

Streamline Health Solutions, Inc.: Streamline Health Expands Presence In Texas with 400-Bed Health System for RevID

Streamline Health GAAP EPS of -$0.61 misses by $0.16, revenue of $4.42M misses by $0.89M

Streamline Health Solutions, Inc.: Streamline Health Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline

Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS...
► Artikel lesen

STREAMLINE HEALTH SOLUTIONS INC. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
10.12.	TEEKAY CORP LTD - 6-K, Report of foreign issuer
10.12.	Teekay Corporation: Teekay Group Announces Changes to Boards of Directors
04.12.	Dividendenbekanntmachungen (04.12.2024)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV BE0974264930 - 1,5 EUR AIRPORTS OF THAILAND PCL TH0765010Z16 0,79 THB 0,0219 EUR AIRPORTS OF THAILAND PCL SDR SGXE27499115 0... ► Artikel lesen
01.11.	Teekay reports Q3 Non-GAAP EPS of $1.84, revenue of $243.3M
31.10.	Teekay declares $1 special dividend

Zeit

Aktuelle Nachrichten

10.12.

TEEKAY CORP LTD - 6-K, Report of foreign issuer

10.12.

Teekay Corporation: Teekay Group Announces Changes to Boards of Directors

04.12.

Dividendenbekanntmachungen (04.12.2024)

Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV BE0974264930 - 1,5 EUR AIRPORTS OF THAILAND PCL TH0765010Z16 0,79 THB 0,0219 EUR AIRPORTS OF THAILAND PCL SDR SGXE27499115 0...
► Artikel lesen

01.11.

Teekay reports Q3 Non-GAAP EPS of $1.84, revenue of $243.3M

31.10.

Teekay declares $1 special dividend

Unternehmen / Aktien	Kurs	%
BIODEXA PHARMACEUTICALS PLC ADR	3,900	-0,51 %
GRANITE REAL ESTATE INVESTMENT TRUST UTS	46,240	-0,43 %
LAKESHORE BIOPHARMA CO LTD	2,860	+45,92 %
SIFY TECHNOLOGIES LIMITED ADR	2,800	-1,41 %
STREAMLINE HEALTH SOLUTIONS INC	3,300	+4,76 %
TEEKAY CORPORATION LTD	6,000	-0,83 %

Unternehmen / Aktien

Kurs

BIODEXA PHARMACEUTICALS PLC ADR

3,900

-0,51 %

GRANITE REAL ESTATE INVESTMENT TRUST UTS

46,240

-0,43 %

LAKESHORE BIOPHARMA CO LTD

2,860

+45,92 %

SIFY TECHNOLOGIES LIMITED ADR